Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7)** is classified as a pseudogene, meaning it is a DNA sequence similar to the protein-coding HNRNPA1 gene but is considered non-functional and does not encode a functional protein[1][10]. Pseudogenes arise from duplication or retrotransposition events and usually accumulate mutations that prevent protein production[7][10]. HNRNPA1P7 should not be confused with the parental HNRNPA1 gene, which encodes a highly abundant and functionally important RNA-binding protein involved in RNA splicing, telomere maintenance, and other crucial cellular processes[2][3][8][11]. By definition and current annotations, HNRNPA1P7 itself is NOT a therapeutic target, enzyme, transporter, or receptor, and there are no known drugs, mechanisms of action, or biomarker roles directly attributed to it[10]. Some pseudogenes have been implicated in gene regulation at the RNA level or associated with disease states via regulatory or competitive endogenous RNA (ceRNA) action, but there is no specific evidence supporting such a function for HNRNPA1P7 at present[7]. **Summary**: - HNRNPA1P7 is a non-functional pseudogene related to the HNRNPA1 family[10][1]. - It is NOT a drug target and encodes no known protein product[10]. - Alternative symbols/aliases: HNRPA1L3[1][10]. - No current evidence links HNRNPA1P7 directly to human disease or therapeutic targeting. - Should be clearly distinguished from the functional HNRNPA1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 7 (HNRNPA1P7).